Tuesday, September 29, 2020
Aphria stock price is impressive compared to similar pot companies
Cronos stock price is struggling over the year
Monday, September 28, 2020
BioNTech stock price increased greatly over the year
The Coronavirus Covid-19 Pandemic needs treatments and vaccines. Investors are interested in the biotech sector for stocks that perform well. Now seems like a good time to invest in biotech stocks. Shares of BioNTech have increased more than 300% since the company's IPO last October. BioNTech stock price is impressive.
BioNTech SE (NASDAQ:BNTX) is an exciting German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases. It researches drugs based on messenger RNA (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases, and also engineered cell therapy, novel antibodies and small molecule immunomodulators as treatment options for cancer. The company developed an mRNA-based human therapeutic for intravenous administration, to bring individualized mRNA-based cancer immunotherapy to clinical trials and to establish its own manufacturing process.
BioNTech's (NASDAQ:BNTX) partnership with Pfizer (NYSE:PFE) is interesting. The 2 companies are currently leading the race for a COVID-19 vaccine with their messenger RNA candidate BNT162b2. The candidate is now in phase 3 clinical testing after delivering a robust immune response against SARS-CoV-2 to almost all participants in phase 1.
Governments of various countries are interested in these studies. If the vaccine is successful in these studies, countries (such as USA and the E.U.) could order millions of doses. BioNTech stock price could go up greatly, if successful.
Next year, BioNTech expects to have the capacity to produce 250 million doses of BNT162b2 every six months (enough for 125 million people). At a certain price of $19.50 per dose - that could be $9.75 billion in annual revenue. The company has a market cap of $15 billion. BioNTech stock price has much room for increasing. BioNTech market share could increase.
On Sept. 15, the company achieved receiving a 375-million-euro grant from the German Federal Ministry of Education and Research for its COVID-19 vaccine program. Look forward to more interesting Data from Pfizer and BioNTech's experimental vaccine (data coming next month).
BioNTech is also working with Fosun Pharma. BioNTech and Fosun Pharma announced (on Aug. 05, 2020) the start of clinical trial of mRNA-based COVID-19 vaccine candidate in China. Read more about it here: https://www.globenewswire.com/news-release/2020/08/05/2073035/0/en/BioNTech-and-Fosun-Pharma-Announce-Start-of-Clinical-Trial-of-mRNA-based-COVID-19-Vaccine-Candidate-in-China.html
Here are the BioNTech SE - Subsidiaries:
BioNTech Innovative Manufacturing Services GmbH
BioNTech Delivery Technologies GmbH
BioNTech Small Molecules GmbH
BioNTech US Inc.
BioNTech Diagnostics GmbH
Biontech Rna Pharmaceuticals Gmbh
BioNTech Cell & Gene Therapies GmbH
BioNTech Research and Development, Inc.
Saturday, September 26, 2020
Canopy Growth and Acreage Implement Amended Arrangement
Artgo Holdings Ltd Stock lost 98% of its value in Crash in November 2019
Chewy stock price: Chewy 2Q Sales Spike 47%; Shares Fall
Hexo Corp (HEXO) runs the risk of being de-listed by the NYSE
Lululemon stock price has fallen 20% this month
Friday, September 25, 2020
Tesla stock price is set to grow and Tesla's new battery technology
Suncor stock price is at the lows
Wednesday, September 23, 2020
Lyft stock price is at about one-third of its initial public offering price
Lyft, Inc. develops, markets, and operates a mobile app, offering vehicles for hire, motorized scooters, a bicycle-sharing system, and useful food delivery. The company is based in San Francisco, California and operates in 644 cities in the United States and 12 cities in Canada. In Canada, Lyft has most business in major cities, such as Toronto, Ottawa and Vancouver. Lyft wants to expand to more Canadian cities in the future. Lyft wants to increase its Lyft market share.
With an impressive 30% market share, Lyft is the second-largest ridesharing company in the United States after Uber. Uber is larger than Lyft. Such ridesharing companies are not available in all areas.
Investors have had a difficult year with Lyft (NASDAQ:LYFT) stock. Shares decreased after a California court battle over worker classification recently intensified. Lyft stock is down about 32% this year. Lyft stock price is currently at about one-third of its initial public offering price. These days, Lyft’s enterprise value is at approximately $7.2 billion. Many analysts think that this is quite a cheap price.
The evolving situation around the COVID-19 Pandemic is sure difficult. However, Lyft’s second-quarter earnings showed signs of post-pandemic recovery. Lyft company is thinking about the health and safety of the Lyft community. Lyft drivers and riders should know the best ways to help protect themselves and others when sharing the ride. According to the CDC and local health officials, people who have been diagnosed with COVID-19, suspect they may have it, or are being evaluated for it should not use rideshare, public transportation, or taxis.
Lyft creates frequent updates about this ongoing situation. Lyft thinks about the official guidance from federal and local health authorities. Of course, safety includes wearing a face covering and keeping the front seat clear. Lyft is still available across North America (in accordance with official mandates).
For Lyft drivers, a Lyft Store has been created to give access to affordable cleaning supplies and face masks. New earning opportunities are being explored and ways to save money through existing programs.
Uber is larger than Lyft. Uber offers ridesharing services outside of USA and Canada. Lyft focuses on rideshare in North America. Uber wants to expand to more markets.
Autonomous vehicles could sure create more competition in the future. GM (NYSE:GM), Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG), and others plan on entering this business. Lyft could try to significantly reduce the number of drivers it usually uses. However, this does not guarantee a certain profit. There are also city regulations to deeply think about.
Lyft and Uber really are the most popular ridesharing companies. Average trip costs for both Uber and Lyft are roughly similar. Lyft stock price has had a lot of turmoil after its IPO. Lyft (NASDAQ:LYFT) continues to struggle to go up in price. It was priced at $72 for its April 2019 IPO. Following this, the shares temporarily went up above $75 before falling lower to $50. The stock went back to $68 at some point. Now, it is at about $27.
Lyft as a company is certainly focused on consumer transportation. It is focused on North America. It is focused on serving drivers and passengers. Lyft is in less countries than Uber.
Uber is in over 60 countries. Although, Uber didn't actually make it in to all of the USA states. Also, at some point, Uber tried China and backed out of China.
Probably Uber will not actually acquire Lyft. That is an unlikely possibility.
Lyft and Uber companies have had some various safety issues. Newspaper articles exist about assaults on passengers (Be Careful). Customers are warned to exercise caution when using ridesharing companies these days.
Autonomous cars could become popular in the future. Companies like Uber and Lyft could profit a lot from this. If you believe in that as an investor, you might get Lyft as an investment.
The Lyft Headquarters are in San Francisco, California, United States. It was founded in June 2012. The CEO is Logan Green (From Jun. 2012). The revenue was 2.157 billion USD (2018). The founders of Lyft are Logan Green and John Zimmer. The company website is lyft.com
The biggest owners of Lyft are:
Rakuten (11%)
General Motors (6.6%)
Fidelity Investments (6.5%)
Andreessen Horowitz (5.3)
CapitalG (4.4%)